| Market Cap | ₹944Cr |
| ROE | -7.10% |
| P/E Ratio(TTM) | -35.00 |
| EPS(TTM) | -2.93 |
| P/B Ratio | 2.72 |
| Dividend Yield | 0.49% |
| Industry P/E | 33.31 |
| Book Value | 37.68 |
| Debt to Equity | 0.25 |
| Face Value | 1 |
| Parent Organisation | Themis Medicare |
| Managing Director | Dr. Sachin Patel |
| NSE Symbol | THEMISMED |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.42 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.89 | ||
| Wockhardt | NA (0.00%) | -459.97 | ||
| Cohance Lifesciences | NA (0.00%) | 65.93 |